DEA Says Cannabis Rescheduling Process Remains Pending Despite Trump Executive Order
Key Takeaway
The DEA confirmed that the cannabis rescheduling appeal process remains administratively pending despite President Trump's December 2025 executive order directing expedited movement from Schedule I to Schedule III. The process had been effectively sidelined since January 2025 after the DEA's administrative law judge retired without a successor ruling on the interlocutory appeals. The DEA indicated no firm timeline for resolving the pending procedural motions, which must be cleared before any final scheduling rule can be published in the Federal Register. For cannabis operators, this means Section 280E federal tax exposure continues indefinitely, and any planned state-level decoupling moves or amended prior-year returns should not be timed to an assumed rescheduling date.
What This Means for Cannabis Businesses
Federal policy changes ripple across the entire cannabis industry. Whether it's rescheduling progress, banking legislation, or court rulings, these developments shape the operating environment for businesses in every legal state. Operators should monitor these developments closely and consult with their legal counsel to understand the implications for their specific markets and operations.
Related Guides
Find Help
Related News
Congressman Presses DOJ and DEA on Cannabis Rescheduling Timeline
New Congressional Research Report on Cannabis Rescheduling Published
Congressional Research Service Releases Comprehensive Cannabis Rescheduling Report
Federal Government Warns About Cannabis and Hemp in Drug Tests
This analysis is based on reporting by Marijuana Moment. Read the original article. CannaBizGuide provides original commentary and analysis - this is not legal or tax advice.